LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+5.57%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$1.13B
AUM Growth
+$64.3M
(+6%)
Cap. Flow
+$14.6M
Cap. Flow
% of AUM
1.29%
Top 10 Holdings %
Top 10 Hldgs %
44.8%
Holding
2,958
New
196
Increased
991
Reduced
1,088
Closed
128
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.24M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$3.66M |
| 3 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$2.96M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$2.82M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.9M |
Top Sells
| 1 |
Honeywell
HON
|
+$2.68M |
| 2 |
Aon
AON
|
+$2.32M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.8M |
| 4 |
NVIDIA
NVDA
|
+$1.79M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$1.64M |
Sector Composition
| 1 | Technology | 17.03% |
| 2 | Financials | 11.91% |
| 3 | Healthcare | 6.6% |
| 4 | Communication Services | 4.01% |
| 5 | Consumer Discretionary | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
2126
DELISTED
Aspen Technology Inc
AZPN
| $3.82K | ﹤0.01% |
16
-27
| -63% | -$6.45K |
|
2127
Madrigal Pharmaceuticals
MDGL
$9.79B
| $3.82K | ﹤0.01% |
18
-13
| -42% | -$2.76K |
|
2128
Merus
MRUS
$5.28B
| $3.8K | ﹤0.01% |
76
-44
| -37% | -$2.2K |
|
2129
Main Street Capital
MAIN
$6.01B
| $3.79K | ﹤0.01% |
76
-4
| -5% | -$199 |
|
2130
Cass Information Systems
CASS
$575M
| $3.78K | ﹤0.01% |
91
| – | – |
|
2131
Chefs' Warehouse
CHEF
$2.69B
| $3.74K | ﹤0.01% |
89
+9
| +11% | +$378 |
|
2132
AtriCure
ATRC
$1.87B
| $3.73K | ﹤0.01% |
133
-258
| -66% | -$7.23K |
|
2133
ImmunityBio
IBRX
$2.45B
| $3.72K | ﹤0.01% |
+1,000
| New | +$3.72K |
|
2134
SSR Mining
SSRM
$4.62B
| $3.71K | ﹤0.01% |
653
-801
| -55% | -$4.55K |
|
2135
Carter's
CRI
$1.1B
| $3.7K | ﹤0.01% |
57
-35
| -38% | -$2.27K |
|
2136
Installed Building Products
IBP
$7.38B
| $3.69K | ﹤0.01% |
15
-6
| -29% | -$1.48K |
|
2137
World Kinect Corp
WKC
$1.44B
| $3.68K | ﹤0.01% |
119
+17
| +17% | +$525 |
|
|
TWO
2138
Two Harbors Investment
TWO
$1.05B
| $3.68K | ﹤0.01% |
265
-259
| -49% | -$3.6K |
|
2139
Immunovant
IMVT
$2.93B
| $3.65K | ﹤0.01% |
128
| – | – |
|
2140
Pediatrix Medical
MD
$1.48B
| $3.63K | ﹤0.01% |
+313
| New | +$3.63K |
|
2141
Tarsus Pharmaceuticals
TARS
$2.19B
| $3.62K | ﹤0.01% |
110
-9
| -8% | -$296 |
|
2142
ProShares UltraShort QQQ
QID
$277M
| $3.62K | ﹤0.01% |
100
-200
| -67% | -$7.23K |
|
2143
RLJ Lodging Trust
RLJ
$1.16B
| $3.61K | ﹤0.01% |
393
+79
| +25% | +$725 |
|
2144
Brunswick
BC
$4.36B
| $3.6K | ﹤0.01% |
43
+15
| +54% | +$1.26K |
|
|
JMIA
2145
Jumia Technologies
JMIA
$1.19B
| $3.58K | ﹤0.01% |
671
| – | – |
|
2146
Kohl's
KSS
$1.81B
| $3.57K | ﹤0.01% |
169
-190
| -53% | -$4.01K |
|
2147
Matsons
MATX
$3.37B
| $3.57K | ﹤0.01% |
25
| – | – |
|
2148
Axcelis
ACLS
$2.71B
| $3.57K | ﹤0.01% |
34
+15
| +79% | +$1.57K |
|
|
CTO
2149
CTO Realty Growth
CTO
$546M
| $3.56K | ﹤0.01% |
+187
| New | +$3.56K |
|
2150
Core & Main
CNM
$9.43B
| $3.55K | ﹤0.01% |
80
-76
| -49% | -$3.37K |
|